Skip to main content
Erschienen in: BMC Pulmonary Medicine 1/2019

Open Access 01.12.2019 | Research article

Reduced forced vital capacity is independently associated with ethnicity, metabolic factors and respiratory symptoms in a Caribbean population: a cross-sectional study

verfasst von: Sateesh Sakhamuri, Fallon Lutchmansingh, Donald Simeon, Liane Conyette, Peter Burney, Terence Seemungal

Erschienen in: BMC Pulmonary Medicine | Ausgabe 1/2019

Abstract

Background

Relationships between low forced vital capacity (FVC), and morbidity have previously been studied but there are no data available for the Caribbean population. This study assessed the association of low FVC with risk factors, health variables and socioeconomic status in a community-based study of the Trinidad and Tobago population.

Methods

A cross-sectional survey was conducted using the Burden of Obstructive Lung Disease (BOLD) study protocol. Participants aged 40 years and above were selected using a two-stage stratified cluster sampling. Generalized linear models were used to examine associations between FVC and risk factors.

Results

Among the 1104 participants studied a lower post-bronchodilator FVC was independently associated with a large waist circumference (− 172 ml; 95% CI, − 66 to − 278), Indo-Caribbean ethnicity (− 180 ml; 95% CI, − 90 to − 269) and being underweight (− 185 ml; 95% CI, − 40 to − 330). A higher FVC was associated with smoking cannabis (+ 155 ml; 95% CI, + 27 to + 282). Separate analyses to examine associations with health variables indicated that participants with diabetes (p = 0∙041), history of breathlessness (p = 0∙007), and wheeze in the past 12 months (p = 0∙040) also exhibited lower post-bronchodilator FVC.

Conclusion

These findings suggest that low FVC in this Caribbean population is associated with ethnicity, low body mass index (BMI), large waist circumference, chronic respiratory symptoms, and diabetes.
Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1186/​s12890-019-0823-9) contains supplementary material, which is available to authorized users.
Abkürzungen
ATS
American thoracic society
BMI
Body mass index
BOLD
Burden of obstructive lung disease
FEV1
Forced expiratory volume in one second
FVC
Forced vital capacity
GDP
Gross domestic product
PURE
Prospective urban rural epidemiology study
THC
Tetrahydrocannabinol

Introduction

More than one and a half centuries after Hutchinson’s design of a spirometer to determine the ‘capacity for life,’ the forced vital capacity (FVC) remains a good predictor of mortality and morbidity. It is related to all-cause mortality even in the general population [1, 2] and can predict it better than systolic blood pressure or body mass index (BMI) [3]. Studies from the developed world have also shown significant associations of FVC with cardiovascular disease [4, 5], cardiovascular events [6], sudden cardiac death [7], metabolic syndrome [8], diabetes [9, 10], and the progression of chronic kidney disease [11]. There are relatively few studies that have examined the risk factors for a low FVC though this has often been attributed to “normal” ethnic differences.
Few spirometry based studies have been conducted on the Caribbean population. These studies have focused on airway obstruction and were performed either in specialty clinics or hospital. Two of them showed low forced expiratory volume in one second (FEV1) or FVC associated with vascular disease [12, 13] and another, FVC with systemic inflammation in diabetic patients [14].
We studied FVC in a national community-based study of non-institutionalized adults aged 40 years and over and living in Trinidad and Tobago, using the Burden of Obstructive Lung Disease (BOLD) study methodology. We investigated potential risk factors as well as the relation of FVC to the health and socioeconomic status. Since the use of universal cut-offs to define abnormal spirometry is contentious [15], we have analysed FVC as a continuous variable to assess its associations, including those with age, sex and ethnicity. In addition, we also studied similar associations with pre-bronchodilator FVC; and pre and post-bronchodilator FEV1.

Methods

Setting

Trinidad and Tobago, a high human development indexed country in the Caribbean, has a uniquely diverse population of predominantly East Indian and African descent. More than half of the population aged 20 years or more (55.5% of males and 66.1% of females) are overweight and obese [16]. The country also possesses a high burden of diabetes and cardiovascular diseases which were determined as the top two causes of death and disability in 2016 (Data was sourced from the IHME GBD profile. http://​www.​healthdata.​org/​trinidad-and-tobago.).

Study design

A cross-sectional survey was conducted across the 15 administrative districts of Trinidad and Tobago, a country with about 1.3 million inhabitants including 39% aged 40 years and above [17]. The study was approved by the ethics committees of the Faculty of Medical Sciences of the University of the West Indies and the Ministry of Health, Trinidad and Tobago.
After obtaining consent, participants aged 40 years and above were asked to answer a core questionnaire focusing on respiratory symptoms, health status, activity limitation, use of healthcare services, and exposure to potential risk factors, such as cigarette smoke. The participants also performed spirometry if there were no contraindications for forced expiratory manoeuvres. Additional questionnaires on indoor air pollution and occupational exposures were administered before the post-bronchodilator spirometry manoeuvres. A wealth score, using a Mokken scale [18] was applied to differentiate the socio-economic status of individual participants. This score was calculated based on the ownership of 10 household assets.

Spirometry

Spirometry was performed according to the 1994 American Thoracic Society (ATS) criteria [19], using the Easy-One portable spirometer (ndd Medizintechnik; Zurich, Switzerland), with the participant in a seated position and pre and post-bronchodilator spirometry (15 min after administering 200 μg salbutamol via metered-dose inhaler with a valve spacer) performed following the BOLD methodology [20]. The difference between the largest and second largest FEV1 and FVC values of < 200 ml was considered as reproducible [20]. A plateau for at least one second after an exhalation time of at least 6 s was considered as a valid end-of-test criterion [19]. Spirometry data were transmitted electronically to the BOLD pulmonary function reading centre in London, where each spirogram was reviewed. A good spirometry had to meet ATS criteria for acceptability, including having at least three attempts, two of which were acceptable [21]. Spirometry technicians were continuously monitored and whenever their quality scores dropped below a pre-set level, they were asked to stop testing, and undergo retraining and recertification. Among the acceptable efforts, the best post-bronchodilator FEV1 and FVC values, even if they were from different curves were used for statistical analyses [19].

Sampling

Participants were selected using two-stage stratified cluster sampling. The study was based on the BOLD protocol that required a minimal sample size of 600 persons above the age of 40 years. The actual sample size, inflated to take into account an expected rate of non-response and unacceptable spirometry (20%) and the clustered nature of the sampling, was 1209 households. A total of 1469 eligible participants were identified from these households and invited to participate.

Statistical analyses

Chi-square tests were used to examine differences in categorical variables and Student’s t-test to examine differences in continuous variables. We checked for differences between responders and non-responders and between those with and without acceptable spirometry. Complex Samples General Linear Models (SPSS Version 25) were used to study associations between FVC and the risk factors. This enabled the application of the stratified cluster sampling structure of the data in the analysis. Weights were also used in the analyses. Base weights were calculated as the inverse of the probability of each participant’s selection. Final weights were determined by adjusting for the age and gender distribution of the national population, using census data.
Age, sex, height, and height-squared are strong predictors of lung function [22] and as these four variables accounted for 60.5% of FVC variance, they were entered as covariates in all analyses. Age squared was not a significant predictor in our analyses and was not used as a covariate. Separate analyses were conducted for each risk factor. All the risk factors that were significantly associated with FVC were subsequently entered in a final model to determine independent predictors. We also used General Linear Models to conduct separate regression analyses to examine associations between FVC and the various health status indicators, and respiratory symptoms. The Complex Samples Analysis module was also used to estimate the prevalence and 95% CI for chronic airflow obstruction.

Results

Out of a total eligible sample of 1469 individuals, 1394 completed the core questionnaire and undertook spirometry. Among them, 1104 successfully performed spirometry, as per the BOLD study quality control criteria (Fig. 1). Of the individuals approached 95% responded (95% response rate) and of these 97% agreed to participate (97% co-operation rate). Spirometry acceptability rate was 79%. Younger participants, those of Indo-Caribbean descent and those who had no chronic respiratory symptoms had higher rates of acceptable spirometry (p < 0.005 in all cases) (Additional file 1: Table S1). Smoking status, BMI and the presence of doctor-diagnosed respiratory disease did not show association with the participants’ spirometry acceptability.
The majority of participants were females (60%), and the sample’s age and ethnic distributions matched well with the recent national census data [17]. Overall, the sample comprised mainly persons of Asian or African ancestry (78%), with secondary or higher level education (53%), who were overweight or obese (70%), and who were exposed to indoor air pollutants (55%) (Table 1). Mean BMI and waist circumferences were higher among Afro-Caribbeans than Indo-Caribbeans (29.59 kg/m2 vs. 27.90 kg/m2; 97.71 cm vs. 95.71 cm, respectively; p < 0.03 in all cases). 27% of the participants gave a history of smoking, which was four times more prevalent in males than females. Among the smokers, more than half were current smokers and one third had also smoked cannabis. 85% of participants had ownership of eight or more of the household amenities in the inventory.
Table 1
Demographics, anthropometry, smoking history and indoor air pollutant exposure of the BOLD Trinidad and Tobago study participants
Variable
Male (443)
Female (661)
Total (1104)
Age in years
 40–49
152 (34.3%)
287 (43.4%)
439 (39.8%)
 50–59
145 (32.7%)
193 (29.2%)
338 (30.6%)
 60–69
90(20.3%)
117 (17.7%)
207 (18.8%)
 70+
56 (12.6%)
64 (9.7%)
120 (10.9%)
Ethnicity
 Indo-Caribbean
191 (43.1%)
269 (40.7%)
460 (41.7%)
 Afro-Caribbean
169 (38.1%)
233 (35.2%)
402 (36.4%)
 Mixed/ other
83 (18.7%)
159 (24.1%)
242 (21.9%)
Highest completed level of education
 Primary /none
205 (46.8%)
314 (47.5%)
521 (47.2%)
 Secondary
134 (30.2%)
216 (32.7%)
350 (31.7%)
 Vocational
79 (17.8%)
90 (13.6%)
169 (15.3%)
 University
23 (5.2%)
41 (6.2%)
64 (5.8%)
Employment status
 Employed
287 (64.8%)
328 (49.6%)
615 (55.7%)
 Not working
17 (3.5%)
23 (3.5%)
40 (3.6%)
 House-person
7 (1.6%)
208 (31.5%)
215 (19.5%)
 Retired
122 (27.5%)
88 (13.3%)
210 (19.0%)
 Other
10 (2.3%)
14 (2.1%)
24 (2.2%)
Wealth score (Mean (SD))
8.85 (1.62)
9.03 (1.31)
8.96 (1.44)
BMI groups
 Underweight (< 18.5 kg/m2)
11 (2.5%)
15 (2.3%)
26 (2.4%)
 Normal (18.5–24.9 kg/m2)
162 (36.6%)
146 (22.1%)
308 (27.9%)
 Overweight (25–29.9 kg/m2)
174 (39.3%)
207 (31.3%)
381 (34.5%)
 Obese (≥30 kg/m2)
96 (21.7%)
293 (44.3%)
389 (35.2%)
Waist circumference
 Normal
300 (67.7%)
162 (24.5%)
461 (41.8%)
 Abnormal (≥102 cm for males, ≥88 cm for females)
143 (32.3%)
499 (75.4%)
642 (58.2%)
Waist Hip ratio
 Normal
152 (34.4%)
205 (31.0%)
357 (32.4%)
 Abnormal (> 0.9 for males, > 0.85 for females)
290 (65.6%)
456 (68.9%)
746 (67.6%)
Smoking status
 Current
121 (27.3%)
36 (5.4%)
157 (14.2%)
 Former
104 (23.5%)
41 (6.2%)
145 (13.1%)
 Never
218 (49.2%)
584 (88.4%)
802 (72.6%)
Pack-year categories
 Never
219 (49.5%)
584 (88.4%)
803 (72.8%)
 0–10
67 (15.2%)
35 (5.3%)
102 (9.2%)
 10–20
56 (12.7%)
21 (3.2%)
77 (7.0%)
 20 +
100 (22.6%)
21 (3.2%)
121 (11.0%)
Ever smoked cannabis
72 (16.3%)
24 (3.6%)
96 (8.7%)
Exposure to second hand smoke
152 (34.3%)
220 (33.3%)
372 (33.7%)
Working in a dusty environment for > 1 year
238 (53.7%)
161 (24.4%)
399 (36.1%)
Indoor open fire with coal used for cooking
87 (19.9%)
99 (15.1%)
186 (17.0%)
Indoor open fire with wood used for cooking
188 (42.9%)
249 (37.9%)
437 (39.9%)
Kerosene used for cooking
163 (37.2%)
249 (37.9%)
412 (37.6%)
Indoor air pollutant exposure: coal, wood or kerosene
 Exposure to one
126 (28.4%)
179 (27.1%)
305 (27.6%)
 Exposure to two
75 (16.9%)
125 (18.9%)
200 (18.1%)
 Exposure to all three
54 (12.2%)
56 (8.5%)
110 (10.0%)
 None
188 (42.4%)
301 (45.5%)
489 (44.3%)
Data are presented as n (%) if not stated otherwise
About one-third of the study participants mentioned at least one of the four symptoms - cough, phlegm, wheeze, and breathlessness in the past 12 months. Also, nearly 10% reported a doctor diagnosed respiratory disease (Table 2). 37% had at least one known co-morbidity, the most prevalent conditions being hypertension (28%) and diabetes (15%). Indo-Caribbeans had a higher diabetes prevalence than the Afro-Caribbeans and Mixed/ other ethnic groups (21, 10, and 12% respectively). This is the only health variable observed to be different between the ethnic groups. Gender differences in health status were noted in breathlessness, (p < 0.001) and doctor-diagnosed respiratory diseases (p = 0.03). In each case, the rates were higher in women than in men (Table 2).
Table 2
Health variables of BOLD Trinidad and Tobago study participants
Variable
Male (443)
Female (661)
Total (1104)
Chronic cough
30 (6.8%)
52 (7.9%)
82 (7.4%)
Chronic phlegm
13 (2.9%)
27 (4.1%)
40 (3.6%)
Wheezing in last 12 months
44 (9.9%)
85 (12.9%)
129 (11.7%)
Breathlessness
54 (12.5%)
136 (21.7%)
190 (17.9%)
Symptomatic (any single respiratory symptom)
134 (30.2%)
248 (37.5%)
382 (34.6%)
Self-reported chronic bronchitis
5 (1.1%)
11 (1.7%)
16 (1.4%)
Doctor diagnosed COPD, chronic bronchitis or emphysema
3 (0.7%)
14 (2.1%)
17 (1.5%)
Doctor diagnosed asthma
34 (7.7%)
75 (11.3%)
109 (9.9%)
Doctor diagnosed respiratory disease
35 (7.9%)
79 (12.0%)
114 (10.3%)
Doctor diagnosed any other medical condition
146 (33.0%)
255 (38.6%)
401 (36.3%)
Doctor diagnosed heart disease
27 (6.1%)
33 (5.0%)
60 (5.4%)
Heart failure
12 (2.7%)
10 (1.5%)
22 (2.0%)
Hypertension
112 (25.3%)
202 (30.6%)
314 (28.4%)
Diabetes
59 (13.3%)
109 (16.5%)
168 (15.2%)
Stroke
5 (1.1%)
4 (0.6%)
9 (0.8%)
Lung cancer
0 (0%)
1 (0.2%)
1 (0.1%)
Tuberculosis
0 (0%)
0 (0%)
0 (0%)
Presence of any single comorbidity
147 (33.2%)
257 (38.9%)
404 (36.6%)
Hospitalised as a child for breathing problems prior age 10
6 (1.4%)
10 (1.5%)
16 (1.5%)
Data are presented as n (%)

Risk factors for low FVC

FVC values were higher in men than women (mean difference = 1070 ml; 95%CI = 991, 1148; p < 0.001). These values were also positively correlated with height (b = 0.052; 95%CI = 0.047, 0.056; p < 0.001) and negatively associated with age (b = − 0.026; 95%CI = − 0.031, − 0.021; p < 0.001).
The mean FVC and FEV1 values adjusted for age, sex, height, and height-squared are tabulated in Table 3 by the potential risk factors. There were significant post-bronchodilator FVC differences by ethnicity (p < 0.001), BMI group (p = 0.024), abnormal waist circumference (p < 0.001), abnormal waist-hip-ratio (p < 0.001), and whether they smoked cannabis (p = 0.004). Indo-Caribbeans showed lower mean FVCs than Afro-Caribbeans and other ethnic groups (Table 3 and Fig. 2). BMI presented a non-linear relation with low FVC. Underweight and obese subjects displayed lower FVCs than those with normal body habitus and overweight people. People with central obesity (abnormal waist circumference and waist-hip ratio) also showed lower FVCs. On the other hand, smokers of cannabis had higher FVC scores than persons who never smoked cannabis. Cigarette smoking status, history of pack-years, second-hand smoking, childhood exposure to smoking, indoor air pollutant exposure, and working in a dusty environment for more than 1 year were not associated with FVC values.
Table 3
Mean adjusteda pre and post-bronchodilator (BD) forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) values (in ml) by the various potential risk factors
Variable
Adjusted Pre-BD Mean FEV1
Adjusted Post-BD Mean FEV1
Adjusted Pre-BD Mean FVC
Adjusted Post-BD Mean FVC
Ethnicity
***
***
***
***
 Indo-Caribbean
2085
2133
2661
2669
 Afro-Caribbean
2212
2268
2853
2880
 Mixed/ other
2284
2331
2951
2952
BMI group
  
*
*
 Underweight (< 18.5 kg/m2)
2098
2146
2739
2736
 Normal (18.5–24.9 kg/m2)
2198
2239
2859
2845
 Overweight (25–29.9 kg/m2)
2200
2257
2821
2852
 Obese (≥30 kg/m2)
2119
2175
2693
2718
Waist circumference
***
***
***
***
Normal
2261
2300
2923
2917
Abnormalb
2094
2158
2674
2710
Waist Hip ratio
***
***
***
***
 Normal
2263
2308
2928
2919
 Abnormalc
2126
2182
2721
2748
Smoking status
 Current smoker
2157
2242
2834
2894
 Ex-smoker
2158
2196
2757
2769
 Never smoker
2176
2223
2784
2791
Smoking pack years
 Never
2176
2223
2783
2790
 0–10
2217
2247
2809
2819
 10–20
2152
2232
2795
2824
 20+
2109
2192
2787
2852
Smoking and respiratory symptoms
 
*
  
 Never smoker with no symptoms
2201
2257
2812
2819
 Never smoker with symptoms
2119
2148
2720
2725
 Ever smoker with no symptoms
2211
2261
2859
2876
 Ever smoker with symptoms
2087
2173
2717
2780
Ever smoked cannabis
  
*
**
 No
2167
2220
2777
2791
 Yes
2255
2302
2984
2996
Second-hand smoking
 No
2176
2234
2773
2817
 Yes
2160
2200
2796
2777
Indoor air pollutant exposure (coal, wood or kerosene)
*
*
*
 
 None
2203
2249
2838
2846
 Exposure to one
2119
2188
2712
2742
 Exposure to two
2223
2266
2821
2831
 Exposure to all three
2089
2132
2735
2753
Worked in a dusty environment for > 1 year
 No
2183
2227
2780
2784
 Yes
2150
2216
2803
2835
Smoking exposure during childhood
*
   
 No
2207
2250
2801
2818
 Yes
2144
2203
2772
2794
Highest level of education
***
*
***
 
 Primary/none
2137
2197
2747
2775
 Secondary
2159
2212
2778
2805
 Vocational
2228
2259
2847
2819
 University
2363
2397
3027
2974
Education – years of schooling
*
   
 0–6 years
2073
2162
2680
2730
 7+ years
2182
2230
2801
2811
Current employment status
 Employed
2195
2240
2805
2815
 Not working
2152
2237
2788
2880
 House person
2140
2215
2717
2753
 Retired
2111
2164
2772
2775
 Other
2361
2362
3082
3024
Significant p-values are shown and denoted by * < 0.05; ** < 0.005; *** < 0.001
aAdjusted for age, sex, height and height-squared with covariates were fixed at the following values: Sex = 0.49; height = 166.43; height-squared = 27,818.0145; Age = 54.93
bAbnormal waist circumference: ≥102 cm for males and ≥ 88 cm for females
cAbnormal waist hip ratio: > 0.9 for males, > 0.85 for females
Multiple regression analysis of the risk factors that were significant after adjusting for age, sex, height, and height-squared indicated that post-bronchodilator FVC was lower in those with increased waist circumference (− 172 ml), Indo-Caribbean participants (− 180 ml) and those who were underweight (− 185 ml), and higher in those who smoked cannabis (+ 155 ml) (Table 4).
Table 4
Results of the general linear models analyses for the significant risk factors for post-bronchodilator forced vital capacity (FVC)
Variables
Categories
Models with Individual Risk Factorsa
Multivariate Modela
p-values (Multivariate model)
Coefficient (ml)
95% CI
Coefficient (ml)
95% CI
Ethnicity
Afro-Caribbean
Baseline
     
< 0.001
Indo-Caribbean
−211
−302
−120
−180
−269
−90
 
Mixed/Other
73
−35
180
79
−27
185
 
BMIb
Normal
Baseline
     
0.01
Underweight
−109
−261
44
−185
−330
−40
 
Overweight
8
−77
93
68
−24
161
 
Obese
− 127
−228
−26
−15
−128
98
 
Abnormal waist circumferencec
Yes
−207
− 296
−119
−172
−278
−66
< 0.001
Abnormal waist–hip ratio d
Yes
− 170
− 246
−95
−71
−145
2
0.057
Ever smoked cannabis
Yes
205
67
342
155
27
282
0.018
aAll models included sex, age, height and height-squared. bNormal BMI = 18.5–25.0 Kg/m2; Underweight BMI < 18.5 Kg/m2; Overweight BMI = 25.0–29.9 Kg/m2; Obese BMI ≥30 Kg/m2. c: Abnormal waist circumference ≥ 102 cm for males and ≥ 88 cm for females. d: Abnormal wait-hip ratio ≥ 0.90 for males and ≥ 0.85 for females
Risk factors for low pre-bronchodilator FVC were of similar significance to those for post-bronchodilator FVC except that indoor air pollution and levels of education were related to pre-bronchodilator FVC but not to post-bronchodilator FVC (Tables 34 and Additional file 1: Table S2).

FVC and health variables

The mean adjusted FVC and FEV1 scores by the various symptoms and health status variables are listed in Table 5. Participants with known diabetes (p = 0.041), with a history of breathlessness (p = 0.007), and wheeze in the past 12 months (p = 0.040) exhibited lower FVC. Diagnosed respiratory disease, hypertension, cardiac disease, history of cough or phlegm, hospitalization before the age of 10 years, and family history of airway disease were not associated with FVC.
Table 5
Mean adjusteda pre and post bronchodilator (BD) forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) values (in ml) by the various health variables
Variable
Adjusted Pre-BD Mean FEV1
Adjusted Post-BD Mean FEV1
Adjusted Pre-BD Mean FVC
Adjusted Post-BD Mean FVC
Hospitalisations prior to the age 10
  
*
 
 No
2171
2223
2786
2801
 Yes
2246
2244
3042
3032
Known asthma
***
***
  
 No
2192
2242
2800
2812
 Yes
1967
2049
2675
2727
Known respiratory disease
***
***
*
 
 No
2195
2244
2803
2815
 Yes
1955
2037
2654
2707
Known hypertension
 No
2153
2197
2806
2820
 Yes
2177
2233
2741
2764
Known diabetes
  
*
*
 No
2127
2166
2802
2818
 Yes
2179
2233
2709
2727
Known cardiac disease
 No
2084
2132
2795
2813
 Yes
2176
2228
2673
2662
Presence of any known comorbidity
  
*
 
 No
2184
2236
2814
2824
 Yes
2146
2199
2742
2770
Chronic cough
 No
2173
2226
2784
2799
 Yes
2133
2182
2807
2827
Phlegm
 No
2172
2223
2792
2806
 Yes
2143
2208
2755
2783
Wheeze in the last 12 months
***
***
***
*
 No
2200
2247
2815
2821
 Yes
1946
2041
2579
2681
Breathlessness
**
**
***
*
 No
2216
2270
2837
2850
 Yes
2071
2121
2678
2708
Family history of airway disease
 No
2167
2220
2782
2799
 Yes
2272
2281
2928
2919
Significant p-values are shown and denoted by * < 0.05; ** < 0.005; *** < 0.001
aAdjusted for age, sex, height and height-squared with covariates were fixed at the following values: Sex = 0.49; height = 166.43; height-squared = 27,818.0145; Age = 54.93

Risk factors for low FEV1

Low post-bronchodilator FEV1 was also independently associated with Indo-Caribbean ethnicity (− 125 ml) and abnormal waist circumference (− 108 ml) (Additional file 1: Table S4). In contrast to FVC, low FEV1 showed an independent association with indoor air pollutant exposure (− 95 ml for all three exposures) but did not show a relation with BMI and cannabis smoking. Further, pre-bronchodilator FEV1 showed associations with abnormal waist-hip ratio (− 69 ml) and highest level of education (+ 168 ml for university education).

Discussion

To our knowledge this is the first published study of lung function in the general population of a Caribbean country and provides new information on the associations of FVC with participant demographics, socio-economic status and morbidity. We found lower FVCs among the Indo-Caribbean population, those with a low BMI and with central obesity. Individuals with a low FVC had more respiratory symptoms.
We observed low FVCs among Indo-Caribbeans compared to Afro-Caribbeans in our study by abut 8% despite the similar prevalence of abnormal waist circumference (57.0% vs. 58.7%; p = 0.751) and a lower prevalence of obesity (30.0% vs. 41.8%; p = 0.008), (Table 6). The lower volumes among Indo-Caribbeans compared with the population of African descendant were consistent with the results from Global differences in lung function by region Prospective Urban Rural Epidemiology (PURE) study [23]. This contrasts with the recently published Canadian Health Measures Survey reference values [24] which showed higher FVCs among those of South Asian compared with those of African descent.
Table 6
Risk Factors by Ethnicity: Afro-Caribbean (n = 402) vs. Indo-Caribbean (n = 460) vs. Mixed/Others (n = 242)
Variable
Afro-Caribbean
Indo-Caribbean
Mixed/ Others
p-value
Gender
   
0∙110
 Male
169 (42.0%)
191 (41.5%)
83 (34.3%)
 
 Female
233 (58∙0%)
269 (58.5%)
159 (65.7%)
 
Age group
   
0.076
 40–49
145 (36.1%)
181 (39.3%)
113 (46.7%)
 
 50–59
134 (33.3%)
136 (29.6%)
68 (28.1%)
 
 60–69
80 (19.9%)
95 (20.7%)
32 (13.2%)
 
 70+
43 (10.7%)
48 (10.4%)
29 (12.0%)
 
BMI groupa
   
0.008
 Underweight
7 (1.7%)
10 (2.2%)
9 (3.7%)
 
 Normal
93 (23.1%)
145 (31.5%)
70 (28.9%)
 
 Overweight
134 (33.3%)
167 (36.3%)
80 (33.1%)
 
 Obesity
168 (41.8%)
138 (30.0%
83 (34.3%)
 
Waist circumferenceb
   
0.751
 Abnormal
236 (58.7%)
262 (57.0%)
144 (59.8%)
 
Waist-Hip ratioc
   
< 0.001
 Abnormal
238 (59.2%)
352 (76.5%)
156 (64.7%)
 
Smoking status
   
0.240
 Current
56 (13.9%)
61 (13.3%)
40 (16.5%)
 
 Ex
54 (13.4%)
52 (11.3%)
39 (16.1%)
 
 Never
292 (72.6%)
347 (75.4%)
163 (67.4%)
 
Smoking pack years
   
0.244
 Never
293 (72.9%)
347 (75.6%)
163 (67.4%)
 
 0–10
35 (8.7%)
41 (8.9%)
26 (10.7%)
 
 10–20
25 (6.2%)
28 (6.1%)
24 (9.9%)
 
 20+
49 (12.2%)
43 (9.4%)
29 (12.0%)
 
Ever smoked Cannabis
   
< 0.001
 Yes
49 (12.6%)
19 (4.2%)
28 (11.7%)
 
Exposure to second-hand smoke
   
0∙001
 Yes
112 (27.9%)
184 (40.0%)
76 (31.4%)
 
Indoor air pollutant exposure
   
< 0.001
 Yes
198 (49.2%)
310 (67.3%)
107 (44.2%)
 
Worked in dusty environment > 1 year
   
0.001
 Yes
174 (43.3%)
153 (33.3%)
72 (29.8%)
 
Smoking exposure during childhood
   
0∙740
 Yes
234 (58.2%)
261 (56.8%)
146 (60.3%)
 
Have respiratory symptoms
   
0.335
 Yes
128 (31.8%)
165 (35.8%)
89 (36.7%)
 
Highest level of education
   
< 0.001
 Primary / None
190 (47.3%)
243 (52.8%)
88 (36.4%)
 
 Secondary
113 (28.1%)
144 (31.3%)
93 (38.4%)
 
 Vocational
72 (17.9%)
54 (11.7%)
43 (17.8%)
 
 University
27 (6.7%)
19 (4.1%)
18 (7.4%)
 
Years of schooling
   
0.200
 7 or more
368 (91.5%)
405 (88.0%)
220 (90.9%)
 
Current employment status
   
< 0.001
 Employed
241 (60.0%)
241 (52.4%)
133 (55.0%)
 
 Not working
16 (4.0%)
9 (2.0%)
15 (6.2%)
 
 House person
34 (8.5%)
139 (30.2%)
42 (17.4%)
 
 Retired
95 (23.6%)
69 (15.0%)
46 (19.0%)
 
 Other
16 (4.0%)
2 (0.4%)
6 (2.5%)
 
Data are presented as n (%). BMI body mass index. aNormal BMI = 18.5–25.0 Kg/m2; Underweight BMI < 18.5 Kg/m2; Overweight BMI = 25.0–29.9 Kg/m2; Obese BMI ≥30 Kg/m2. bAbnormal waist circumference: ≥ 102 cm for males and ≥ 88 cm for females. c: Abnormal wait-hip ratio ≥ 0.90 for males and ≥ 0.85 for females
FVC in our population showed a nonlinear relation with BMI, comprising low volumes among those with both low and high BMI. Obesity and abnormal waist circumference related reduction in vital capacity can be explained by restriction of inspiration. Obesity-associated reduction in FVC has been observed in many studies and has been attributed to an increased impedance of the chest wall [2527]. Studies have also shown that a 1 cm increment in waist circumference can decrease FVC by 13 ml [28]. Waist circumference is considered as a superior indicator of intra-abdominal fat [29] and may be a good gauge of its effect on diaphragm function and other ventilatory mechanics. When we adjusted FVC measures for both BMI and waist circumference the association of low FVC with a high BMI disappeared and that with waist circumference was essentially unchanged, suggesting that the link between a low FVC and a high BMI is mediated largely through mechanical effects of an increase in intra-abdominal fat. The association of a low FVC with a low BMI, however, was strengthened in the adjusted model, suggesting a more direct association. Low vital capacities have also been reported to be associated with low birth weight [30], though we have no estimate of birth weight in this population.
An increased FVC among cannabis smokers has also been reported in previous studies [3133]. The exact cause for this increase is unclear but could reflect a “healthy smoker” effect, those with poor lung function being less likely to take up smoking cannabis. The effect of cannabis on FVC and the lack of association with FEV1 could be explained by training effects on the respiratory muscles with the habitual deep inhalations during cannabis smoking, and the likely acute bronchodilatory effects of delta-9-tetrahydrocannabinol (THC) [34]. These findings warrant careful interpretation given the potential adverse public health implications of long-term cannabis use including emphysematous bullae [35] and a twofold increased odds of obstructive lung disease [32]. Apart from cigarette smoking, the statistically nonsignificant associations with environmental factors such as exposure to indoor air pollution or solid fuel and working in a dusty environment on FVC have been observed in other studies as well [36].
We found that participants who had a low FVC had a history of wheezing or shortness of breath. This relationship has been published in previous studies [37, 38]. A low FVC was also associated with comorbidities especially diabetes. Earlier studies have found that individuals in the lowest quartile for FVC are more likely to develop insulin resistance [8] and diabetes [9] over time. A meta-analysis of 40 publications has shown a significantly lower FVC and FEV1 with preserved FEV1/FVC ratio among diabetic patients [39].
Although low socioeconomic status and poor education have been associated with reduced ventilatory function and chronic lung disease, this was not found in the current study. This may be due to either high per capita gross domestic product (GDP US$ 17,879 in 2015) with minor economic inequalities (GINI index 40.3 in 2010) among the local community (Data was sourced from the IMF press release no. 17/423. http://​www.​imf.​org/​en/​News/​Articles/​2017/​11/​06/​pr17423-imf-executive-board-concludes-article-iv-consultation-with-trinidad-and-tobago) compared to other developing countries or ineffectiveness of the tools used to distinguish the economic variations in this population. Although the wealth scale that we used has been shown to have good reliability [18] and has been associated with educational attainment, the majority of the sample possessed eight or more out of ten household amenities. This was similar to the situation seen in wealthy countries like Saudi Arabia [40]. The scale may need customization.
Limitations of the current study include the cross-sectional nature of the research, reliance on self-reported data and limited tools to measure the socioeconomic variations in the local population. However, there were many strengths such as our high response and cooperation rates. The diverse and evenly distributed ethnic distribution in the population, which was reflected in the sample, allowed for the examination of ethnic differences. Other strengths included the application of robust BOLD methodology, sound participant sampling, and quality assured spirometry. Most importantly we avoided the arbitrary use of ‘normal’ values for lung function assessment.

Conclusions

Low FVC was associated with ethnicity, central obesity, chronic respiratory symptoms, and comorbidities like diabetes. Longitudinal studies are required to estimate the mortality and morbidity risk with diminished FVCs and also to compare the health effects of reduced FVC compared to reduced static lung volumes. Identifying individuals with low FVC may have clinical and public health importance and a better understanding of this condition and its origins is needed.

Acknowledgments

We sincerely thank the BOLD central office, Imperial College, London for guidance and spirometry quality control, BOLD Trinidad and Tobago Steering Committee for technical advisory support, The Central Statistical Office (CSO) Trinidad and Tobago for providing population sampling support, and The Thoracic Society of Trinidad and Tobago (TSOTT) for professional collaboration.

Funding

The BOLD Trinidad and Tobago study was supported by a grant from the Ministry of Health, the Republic of Trinidad and Tobago, and a Research and Development grant from The University of the West Indies, St. Augustine. Some financial or other support was also obtained from Astra-Zeneca, Boehringer Ingelheim, Glaxo Smith Kline and Novartis. The BOLD coordinating centre was funded by the Wellcome Trust (085790/Z/08/Z). The funding bodies played no role in study design and data collection, interpretation of data or writing of the manuscript.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Ethical approval was granted by the ethics committees of the Faculty of Medical Sciences of the University of the West Indies and the Ministry of Health, Trinidad and Tobago. All participants signed the written consent to participate.
Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Burney PG, Hooper R. Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax. 2011;66(1):49–54.CrossRef Burney PG, Hooper R. Forced vital capacity, airway obstruction and survival in a general population sample from the USA. Thorax. 2011;66(1):49–54.CrossRef
2.
Zurück zum Zitat Magnussen C, Ojeda FM, Rzayeva N, et al. FEV1 and FVC predict all-cause mortality independent of cardiac function — results from the population-based Gutenberg health study. Int J Cardiol. 2017;234:64–8.CrossRef Magnussen C, Ojeda FM, Rzayeva N, et al. FEV1 and FVC predict all-cause mortality independent of cardiac function — results from the population-based Gutenberg health study. Int J Cardiol. 2017;234:64–8.CrossRef
3.
Zurück zum Zitat Gupta RP, Strachan DP. Ventilatory function as a predictor of mortality in lifelong non-smokers: evidence from large British cohort studies. BMJ Open. 2017;7(7):e015381.CrossRef Gupta RP, Strachan DP. Ventilatory function as a predictor of mortality in lifelong non-smokers: evidence from large British cohort studies. BMJ Open. 2017;7(7):e015381.CrossRef
4.
Zurück zum Zitat Schroeder EB, Welch VL, Couper D, et al. Lung function and incident coronary heart disease: the atherosclerosis risk in communities study. Am J Epidemiol. 2003;158:1171–81.CrossRef Schroeder EB, Welch VL, Couper D, et al. Lung function and incident coronary heart disease: the atherosclerosis risk in communities study. Am J Epidemiol. 2003;158:1171–81.CrossRef
5.
Zurück zum Zitat Mannino DM, Davis KJ, Disantostefano RL. Chronic respiratory disease, comorbid cardiovascular disease and mortality in a representative adult US cohort. Respirology. 2013;18(7):1083–8.PubMed Mannino DM, Davis KJ, Disantostefano RL. Chronic respiratory disease, comorbid cardiovascular disease and mortality in a representative adult US cohort. Respirology. 2013;18(7):1083–8.PubMed
6.
Zurück zum Zitat Johnston AK, Mannino DM, Hagan GW, et al. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax. 2008;63(7):599–605.CrossRef Johnston AK, Mannino DM, Hagan GW, et al. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax. 2008;63(7):599–605.CrossRef
7.
Zurück zum Zitat Kurl S, Jae SY, Kauhanen J, et al. Impaired pulmonary function is a risk predictor for sudden cardiac death in men. Ann Med. 2015;47(5):381–5.CrossRef Kurl S, Jae SY, Kauhanen J, et al. Impaired pulmonary function is a risk predictor for sudden cardiac death in men. Ann Med. 2015;47(5):381–5.CrossRef
8.
Zurück zum Zitat Lee HM, Chung SJ, Lopez VA, et al. Association of FVC and total mortality in US adults with metabolic syndrome and diabetes. Chest. 2009;136(1):171–6.CrossRef Lee HM, Chung SJ, Lopez VA, et al. Association of FVC and total mortality in US adults with metabolic syndrome and diabetes. Chest. 2009;136(1):171–6.CrossRef
9.
Zurück zum Zitat Engström G, Hedblad B, Nilsson P, et al. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med. 2003;253(5):574–81.CrossRef Engström G, Hedblad B, Nilsson P, et al. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med. 2003;253(5):574–81.CrossRef
10.
Zurück zum Zitat Yeh HC, Punjabi NM, Wang NY, et al. Vital capacity as a predictor of incident type 2 diabetes: the atherosclerosis risk in communities study. Diabetes Care. 2005;28(6):1472–9.CrossRef Yeh HC, Punjabi NM, Wang NY, et al. Vital capacity as a predictor of incident type 2 diabetes: the atherosclerosis risk in communities study. Diabetes Care. 2005;28(6):1472–9.CrossRef
11.
Zurück zum Zitat Sumida K, Kwak L, Grams ME, et al. Lung function and incident kidney disease: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis. 2017;70(5):675–85.CrossRef Sumida K, Kwak L, Grams ME, et al. Lung function and incident kidney disease: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis. 2017;70(5):675–85.CrossRef
12.
Zurück zum Zitat Seemungal T, Harrinarine R, Rios M, et al. Obstructive lung disease in acute medical patients. West Indian Med J. 2008;57:7–14.PubMed Seemungal T, Harrinarine R, Rios M, et al. Obstructive lung disease in acute medical patients. West Indian Med J. 2008;57:7–14.PubMed
13.
Zurück zum Zitat Thorington P, Rios M, Avila G, et al. Prevalence of chronic obstructive pulmonary disease among stable chronic disease subjects in primary care in Trinidad, West Indies. J Thorac Dis. 2011;3(3):177–82.PubMedPubMedCentral Thorington P, Rios M, Avila G, et al. Prevalence of chronic obstructive pulmonary disease among stable chronic disease subjects in primary care in Trinidad, West Indies. J Thorac Dis. 2011;3(3):177–82.PubMedPubMedCentral
14.
Zurück zum Zitat Pinto Pereira LM, Seemungal TAR, Teelucksingh S, et al. Restrictive pulmonary deficit is associated with inflammation in sub-optimally controlled obese diabetics. J Thorac Dis. 2013;5(3):289–97.PubMedPubMedCentral Pinto Pereira LM, Seemungal TAR, Teelucksingh S, et al. Restrictive pulmonary deficit is associated with inflammation in sub-optimally controlled obese diabetics. J Thorac Dis. 2013;5(3):289–97.PubMedPubMedCentral
15.
Zurück zum Zitat Linares-Perdomo O, Hegewald M, Collingridge DS, et al. Comparison of NHANES III and ERS/GLI 12 for airway obstruction classification and severity. Eur Respir J. 2016;48(1):133–41.CrossRef Linares-Perdomo O, Hegewald M, Collingridge DS, et al. Comparison of NHANES III and ERS/GLI 12 for airway obstruction classification and severity. Eur Respir J. 2016;48(1):133–41.CrossRef
16.
Zurück zum Zitat Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study Lancet. 2013;384(9945):766–81. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study Lancet. 2013;384(9945):766–81.
18.
Zurück zum Zitat Townend J, Minelli C, Harrabi I, et al. Development of an international scale of socio-economic position based on household assets. Emer Themes Epidemiol. 2015;12:13.CrossRef Townend J, Minelli C, Harrabi I, et al. Development of an international scale of socio-economic position based on household assets. Emer Themes Epidemiol. 2015;12:13.CrossRef
19.
Zurück zum Zitat American Thoracic Society Statement. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152(3):1107–36.CrossRef American Thoracic Society Statement. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152(3):1107–36.CrossRef
20.
Zurück zum Zitat Buist AS, Vollmer WM, Sullivan SD, et al. The burden of obstructive lung disease initiative (BOLD): rationale and design. COPD. 2005;2(2):277–83.CrossRef Buist AS, Vollmer WM, Sullivan SD, et al. The burden of obstructive lung disease initiative (BOLD): rationale and design. COPD. 2005;2(2):277–83.CrossRef
21.
Zurück zum Zitat Hankinson JL, Eschenbacher B, Townsend M, et al. Use of forced vital capacity and forced expiratory volume in 1 second quality criteria for determining a valid test. Eur Respir J. 2015;45(5):1283–92.CrossRef Hankinson JL, Eschenbacher B, Townsend M, et al. Use of forced vital capacity and forced expiratory volume in 1 second quality criteria for determining a valid test. Eur Respir J. 2015;45(5):1283–92.CrossRef
22.
Zurück zum Zitat Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999;159(1):179–87.CrossRef Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999;159(1):179–87.CrossRef
23.
Zurück zum Zitat Duong M, Islam S, Rangarajan S, et al. Global differences in lung function by region (PURE): an international, community-based prospective study. Lancet Respir Med. 2013;1:599–609.CrossRef Duong M, Islam S, Rangarajan S, et al. Global differences in lung function by region (PURE): an international, community-based prospective study. Lancet Respir Med. 2013;1:599–609.CrossRef
24.
Zurück zum Zitat Coates AL, Wong SL, Tremblay C, et al. Reference equations for spirometry in the Canadian population. Ann Am Thorac Soc. 2016;13(6):833–41.CrossRef Coates AL, Wong SL, Tremblay C, et al. Reference equations for spirometry in the Canadian population. Ann Am Thorac Soc. 2016;13(6):833–41.CrossRef
25.
Zurück zum Zitat Obaseki DO, Erhabor GE, Awopeju OF, et al. Reduced forced vital capacity in an African population. Prevalence and risk factors. Ann Am Thorac Soc. 2017;14(5):714–21.CrossRef Obaseki DO, Erhabor GE, Awopeju OF, et al. Reduced forced vital capacity in an African population. Prevalence and risk factors. Ann Am Thorac Soc. 2017;14(5):714–21.CrossRef
26.
Zurück zum Zitat Kurth L, Hnizdo E. Change in prevalence of restrictive lung impairment in the U.S. population and associated risk factors: the National Health and nutrition examination survey (NHANES) 1988–1994 and 2007–2010. Multidiscip Respir Med. 2015;10:7.CrossRef Kurth L, Hnizdo E. Change in prevalence of restrictive lung impairment in the U.S. population and associated risk factors: the National Health and nutrition examination survey (NHANES) 1988–1994 and 2007–2010. Multidiscip Respir Med. 2015;10:7.CrossRef
27.
Zurück zum Zitat Thyagarajan B, Jacobs DR Jr, Apostol GG, et al. Longitudinal association of body mass index with lung function: the CARDIA study. Respir Res. 2008;9:31.CrossRef Thyagarajan B, Jacobs DR Jr, Apostol GG, et al. Longitudinal association of body mass index with lung function: the CARDIA study. Respir Res. 2008;9:31.CrossRef
28.
Zurück zum Zitat Chen Y, Rennie D, Cormier YF, et al. Waist circumference is associated with pulmonary function in normal-weight, overweight, and obese subjects. Am J Clin Nutr. 2007;85(1):35–9.CrossRef Chen Y, Rennie D, Cormier YF, et al. Waist circumference is associated with pulmonary function in normal-weight, overweight, and obese subjects. Am J Clin Nutr. 2007;85(1):35–9.CrossRef
29.
Zurück zum Zitat Klein S, Allison DB, Heymsfield SB, et al. Waist circumference and cardiometabolic risk: a consensus statement from shaping America’s health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care. 2007;30(6):1647–52.CrossRef Klein S, Allison DB, Heymsfield SB, et al. Waist circumference and cardiometabolic risk: a consensus statement from shaping America’s health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care. 2007;30(6):1647–52.CrossRef
30.
Zurück zum Zitat Saad NJ, Patel J, Burney P, et al. Birth weight and lung function in adulthood: a systematic review and meta-analysis. Ann Am Thorac Soc. 2017;14(6):994–1004.CrossRef Saad NJ, Patel J, Burney P, et al. Birth weight and lung function in adulthood: a systematic review and meta-analysis. Ann Am Thorac Soc. 2017;14(6):994–1004.CrossRef
31.
Zurück zum Zitat Hancox RJ, Poulton R, Ely M, et al. Effects of cannabis on lung function: a population-based cohort study. Eur Respir J. 2010;35(1):42–7.CrossRef Hancox RJ, Poulton R, Ely M, et al. Effects of cannabis on lung function: a population-based cohort study. Eur Respir J. 2010;35(1):42–7.CrossRef
32.
Zurück zum Zitat Kempker JA, Honig EG, Martin GS. The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and nutrition examination study. Ann Am Thorac Soc. 2015;12(2):135–41.CrossRef Kempker JA, Honig EG, Martin GS. The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and nutrition examination study. Ann Am Thorac Soc. 2015;12(2):135–41.CrossRef
33.
Zurück zum Zitat Pletcher MJ, Vittinghoff E, Kalhan R, et al. Association between marijuana exposure and pulmonary function over 20 years. JAMA. 2012;307(2):173–81.CrossRef Pletcher MJ, Vittinghoff E, Kalhan R, et al. Association between marijuana exposure and pulmonary function over 20 years. JAMA. 2012;307(2):173–81.CrossRef
34.
Zurück zum Zitat Tashkin DP, Shapiro BJ, Frank IM. Acute pulmonary physiologic effects of smoked marijuana and oral (Delta)9 -tetrahydrocannabinol in healthy young men. N Engl J Med. 1973;289(7):336–41.CrossRef Tashkin DP, Shapiro BJ, Frank IM. Acute pulmonary physiologic effects of smoked marijuana and oral (Delta)9 -tetrahydrocannabinol in healthy young men. N Engl J Med. 1973;289(7):336–41.CrossRef
35.
Zurück zum Zitat Hii SW, Tam JDC, Thompson BR, et al. Bullous lung disease due to marijuana. Respirology. 2008;13(1):122–7.CrossRef Hii SW, Tam JDC, Thompson BR, et al. Bullous lung disease due to marijuana. Respirology. 2008;13(1):122–7.CrossRef
36.
Zurück zum Zitat Amaral AFS, Patel J, Kato BS, et al. Airflow obstruction and use of solid fuels for cooking or heating: BOLD results. Am J Respir Crit Care Med. 2018;197(5):595–610.CrossRef Amaral AFS, Patel J, Kato BS, et al. Airflow obstruction and use of solid fuels for cooking or heating: BOLD results. Am J Respir Crit Care Med. 2018;197(5):595–610.CrossRef
37.
Zurück zum Zitat Grønseth R, Vollmer WM, Hardie JA, et al. Predictors of dyspnoea prevalence: results from the BOLD study. Eur Respir J. 2014;43(6):1610–20.CrossRef Grønseth R, Vollmer WM, Hardie JA, et al. Predictors of dyspnoea prevalence: results from the BOLD study. Eur Respir J. 2014;43(6):1610–20.CrossRef
38.
Zurück zum Zitat Soriano JB, Miravitlles M, García-Río F, et al. Spirometrically-defined restrictive ventilatory defect: population variability and individual determinants. Prim Care Respir J. 2012;21(2):187–93.CrossRef Soriano JB, Miravitlles M, García-Río F, et al. Spirometrically-defined restrictive ventilatory defect: population variability and individual determinants. Prim Care Respir J. 2012;21(2):187–93.CrossRef
39.
Zurück zum Zitat van den Borst B, Gosker HR, Zeegers MP, et al. Pulmonary function in diabetes: a metaanalysis. Chest. 2010;138(2):393–406.CrossRef van den Borst B, Gosker HR, Zeegers MP, et al. Pulmonary function in diabetes: a metaanalysis. Chest. 2010;138(2):393–406.CrossRef
40.
Zurück zum Zitat Townend J, Minelli C, Mortimer K, et al. The association between chronic airflow obstruction and poverty in 12 sites of the multinational BOLD study. Eur Respir J. 2017;49(6):1601880.CrossRef Townend J, Minelli C, Mortimer K, et al. The association between chronic airflow obstruction and poverty in 12 sites of the multinational BOLD study. Eur Respir J. 2017;49(6):1601880.CrossRef
Metadaten
Titel
Reduced forced vital capacity is independently associated with ethnicity, metabolic factors and respiratory symptoms in a Caribbean population: a cross-sectional study
verfasst von
Sateesh Sakhamuri
Fallon Lutchmansingh
Donald Simeon
Liane Conyette
Peter Burney
Terence Seemungal
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
BMC Pulmonary Medicine / Ausgabe 1/2019
Elektronische ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-019-0823-9

Weitere Artikel der Ausgabe 1/2019

BMC Pulmonary Medicine 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.